Page 5 - Thomas Sandgaard News Today

Should You Buy or Sell Zynex Stock? Get The Latest ZYXI Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Zynex (NASDAQ:ZYXI – Get Rating) issued an update on its second quarter 2023 earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.03-$0.07 for the period, compared to the consensus earnings per share estimate of $0.08. The company issued revenue guidance of $43.50 million-$45.50 million, compared to the consensus revenue estimate […]

Zynex (NASDAQ:ZYXI – Get Rating) updated its FY23 earnings guidance on Tuesday. The company provided EPS guidance of $0.40-0.50 for the period, compared to the consensus EPS estimate of $0.47. The company issued revenue guidance of $180-200 million, compared to the consensus revenue estimate of $191.24 million. Zynex also updated its Q1 guidance to $0.00-0.03 […]

Zynex (NASDAQ:ZYXI – Get Rating) updated its first quarter earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.00-0.03 for the period, compared to the consensus estimate of $0.01. The company issued revenue guidance of $39-41 million, compared to the consensus revenue estimate of $39.61 million. Zynex also updated its FY23 […]

Zynex (NASDAQ:ZYXI – Get Rating) issued an update on its FY23 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.40-0.50 for the period, compared to the consensus estimate of $0.47. The company issued revenue guidance of $180-200 million, compared to the consensus revenue estimate of $191.24 million. Zynex also […]

/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

This is the second consecutive year Zynex has appeared on the Financial Times annual list of The Americas' Fastest Growing Companies. 

Zynex (NASDAQ:ZYXI – Get Rating) had its target price boosted by LADENBURG THALM/SH SH from $27.00 to $28.00 in a research report sent to investors on Tuesday, The Fly reports. The firm currently has a buy rating on the stock. A number of other equities research analysts also recently commented on ZYXI. Piper Sandler upgraded […]

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

Operator: Good morning, ladies and gentlemen and welcome to the Zynex Fourth Quarter 2022 Earnings Conference Call. Please note this event is being recorded.